Basic & Clinical Medicine ›› 2014, Vol. 34 ›› Issue (10): 1381-1385.

Previous Articles     Next Articles

TBB inhibits the proliferation and migration of thyroid papillary carcinoma cell line FTC133 via WNT/β-CATENIN signaling pathway

  

  • Received:2014-02-21 Revised:2014-05-24 Online:2014-10-05 Published:2014-09-25

Abstract: Objective To observe the effects of 4,5,6,7-tetrabromobenzotriazole(TBB) on the expressions ofCK2ɑ,β-CATENIN and SURVIVINin thyroid papillary carcinoma cell line FTC133and to explore the possible underlyingmechanism. Methods FTC133 cellswere cultured in vitro and divided into control group(DMSO), TBBgroups(12.5, 25, 50μmol/L)randomly. The proliferationrateand migration of FTC133 cells was detected byMTTand wound healing method. TheCK2ɑ, β-CATENIN and SURVIVIN mRNA and protein expression levelswere determined by RT–PCR and Western blot. Results Compared with control group, the proliferationrate and migration of FTC133 cells wereinhibited by TBBin a dose–dependentmanner(P<0.01).The expression levels of mRNA and protein ofCK2ɑ were significantly decreased in the presence of different TBB in FTC133 cells(P<0.01), the protein expression level of β-CATENIN and SURVIVIN were decreased, too(P<0.01).Conclusion TBB inhibits the proliferation and migration of thyroid papillary carcinoma cell line FTC133 via WNT/β-CATENIN signaling pathway.

Key words: TBB, thyroid papillary carcinoma, CK2ɑ, β-CATENIN, SURVIVIN